Dongkook Wins Patent from Japan for Leuprolin Acetate Preparation

Dongkook Pharmaceutical announced that it has successfully obtained a patent from Japan for the company's proprietary preparation technology of leuprolin acetate, which is marketed under the tradename Lorelin Depot Injection,

According to the company, the preparation technology for leuprolin acetate, an anti-cancer agent, uses the micro-encapsulated formulation, which enables continuous rel...